DAIC

MARCH 6, 2024

milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.

Heart Disease 105

Heart Disease Heart Attack Heart attacks Technology 105

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

Ischemia 110

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease 110

DAIC

FEBRUARY 13, 2024

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Earls, MD , Chief Medical Officer of Cleerly.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

MIBHS

FEBRUARY 28, 2025

Heart disease remains one of the leading causes of death worldwide, often attributed to a mix of lifestyle choices, environmental factors, and genetic predispositions. Understanding the Genetic Connection to Heart Disease Your genetic makeup plays a vital role in shaping your heart health.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

Science Daily - Heart Disease

SEPTEMBER 18, 2024

A team developed a nanoparticle technology that offers an effective solution to diagnose and treat atherosclerosis, in a non-invasive manner.

Atherosclerosis 113

Atherosclerosis Technology Research Plaque 113

DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By

Cancer 45

Cancer Atrial Fibrillation Sudden Cardiac Death Heart Failure 45

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. billion adults worldwide. Circulation. 2017; 135: e146.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105